Attention Providers of Section 26: Draft Rate Model Public Review and Comment

Earlier this year MaineCare conducted a survey of Day Health service providers. We used the provider responses to create draft rate models for the services as part of the rate determination process. We outlined this process during our kick-off meeting with providers on August 31, 2022. This message outlines the next steps in the process.  

PUBLIC REVIEW AND COMMENT 

Attention Providers of Section 2: Draft Rate Model Public Review and Comment

Earlier this year MaineCare conducted a survey of Adult Family Care Home service providers. We used the provider responses to create draft rate models for the services as part of the rate determination process. We outlined this process during our kick-off meeting with providers on September 1, 2022. This message outlines the next steps in the process.  

PUBLIC REVIEW AND COMMENT 

CORRECTION to 2022 Rate Update Message, CR 112541, for Section 43 Providers

This is a correction to the bulletin sent on October 28, 2022, regarding rate updates for Hospice Services. The previous message incorrectly stated that the rates affected Section 90 instead of Section 43.

On September 28, 2022, some rates for Chapter 1, Section 43 have been updated in MIHMS effective October 1, 2022, and are now available for viewing on the Health PAS Online Portal.  

Proposed homepage

The Division of Licensing & Certification (DLC) provides regulatory oversight of medical and long-term care facilities in Maine. This includes oversight of the CNA registry, criminal background checks for employers to ensure staff are safe to care for our vulnerable citizens, and investigations into allegations of unsafe practices/events in facilities as diverse as hospitals, nursing homes, assisted living facilities, and group homes.

  Emotional Dysregulation with Explosive Outbursts 

                                        

                                                         November 9, 2022, 7:30-8:30 AM  

                                                                             Via Zoom Webinar!  

Attention Section 90 Providers: Updated Changes for Billing Topical Fluoride Varnish, CR 111959

In a July 22, 2022, e-message the Department indicated Current Procedural Terminology (CPT) code 99188 (application of topical fluoride varnish by a physician or other qualified health professional) would be reimbursed the same rate as Current Dental Terminology (CDT) code D1206, Topical Application of Fluoride Var

Use of Palivizumab Prophylaxis to Prevent Hospitalization from Severe RSV Infection

The Office of MaineCare Services (OMS), in coordination with their Pharmacy Benefits Manager Change Healthcare (CHC), review data from the National Respiratory and Enteric Virus Surveillance System (NREVSS) to track the epidemic season for Respiratory Syncytial Virus (RSV). Palivizumab is indicated for the prevention of serious lower respiratory tract disease caused by RSV in infants. Peak RSV activity typically occurs between November and March.

Subscribe to